2014-2026 Global Biologics (Biosimilar) Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID : Maia-14981902 | Publishing Date : 10-Dec-2019 | No. of pages : 127
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
3sbio
Teva
Amgen
Biotech Pharma
Johnson & Johnson
CP Guojian Pharmacy
Novo Nordisk
Merck
Lilly
Mylan
Hospira
Novartis
Changchun High tech
AbbVie
Sandoz
Gelgen Biopharma
Pfizer
Roche
Sanofi
Major Types Covered
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Major Applications Covered
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region